Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. (Q37375714)

20 August 2017

1 reference

title

Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. (English)

1 reference

chronic obstructive pulmonary disease

20 August 2017

0 references

0 references

0 references

6

Marc Decramer

1 reference

20 August 2017

5

Chantal Mathieu

1 reference

20 August 2017

4

Roger Bouillon

1 reference

20 August 2017

Wim Janssens

1

1 reference

20 August 2017

An Lehouck

series ordinal

2

1 reference

20 August 2017

Claudia Carremans

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

22 January 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

20 August 2017

1 reference

20 August 2017

179

1 reference

20 August 2017

8

1 reference

20 August 2017

630-636

1 reference

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

20 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Genetics and biology of vitamin D receptor polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D and health: perspectives from mice and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

13th Workshop consensus for vitamin D nutritional guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Effect of Vitamin D on falls: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Smoking patterns in African Americans and whites with advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D binding protein variants and the risk of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D binding protein, bone status and body composition in community-dwelling elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Genetics of chronic obstructive pulmonary disease, beyond a1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Prevalence of vitamin D insufficiency in an adult normal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Estimates of optimal vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Vitamin D toxicity, policy, and science

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The risk of osteoporosis in Caucasian men and women with obstructive airways disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Relationship of lung function to severity of osteoporosis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Reduced pulmonary function in patients with spinal osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Inflammation of the airways and lung parenchyma in COPD: role of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Elastin fragments drive disease progression in a murine model of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Neutrophilic airway inflammation and IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Systemic effects of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Exercise training in COPD: how to distinguish responders from nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Pulmonary rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

The use of statins and lung function in current and former smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

From COPD to chronic systemic inflammatory syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1576PP

10.1164/RCCM.200810-1576PP

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference